Home Ingredients Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)
Weight ManagementLiver HealthMetabolic HealthAntioxidant

Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)

Undaria pinnatifida (wakame) + Punica granatum
Evidence Level
Limited
3 Clinical Trials
7 Documented Benefits
2/5 Evidence Score

Branded patented blend from Nektium of wakame brown seaweed (Undaria pinnatifida) extract containing fucoxanthin plus pomegranate seed oil. Abidov 2010 (, Diabetes Obes Metab 12(1):72-81) is the pivotal 16-week RCT in 151 obese premenopausal women (113 with NAFLD, 38 with normal liver fat) — 600 mg/day Xanthigen® (300 mg PSO + 300 mg brown seaweed extract with 2.4 mg fucoxanthin) on 1,800 kcal/day diet. Significant body weight, body fat, and liver fat reductions; resting energy expenditure increased ~400 kcal/day; ALT/AST/GGT reductions in NAFLD subgroup. The 400 kcal/day REE increase via UCP1-mediated thermogenesis is genuinely distinctive among weight-management supplements. Honest caveat: only one published human weight-management trial of this magnitude — independent replication remains limited.

Studied Dose PIVOTAL: 600 mg Xanthigen®/day × 16 weeks (300 mg PSO + 300 mg brown seaweed extract with 2.4 mg fucoxanthin). On 1,800 kcal/day diet (50% carb / 30% protein / 20% fat). Take with food. Pregnancy: avoid. Thyroid medication users: caution (iodine content from brown seaweed).
Active Compound Fucoxanthin (allenic carotenoid from brown seaweed Undaria pinnatifida wakame) + pomegranate seed oil (rich in punicic acid — conjugated linolenic acid). Patented synergistic combination

Benefits

Weight management and visceral fat in obese women

Abidov M et al. 2010 (, Diabetes Obes Metab 12(1):72-81) — 16-week double-blind randomized placebo-controlled trial in 151 non-diabetic obese premenopausal women on 1,800 kcal/day energy-restricted diet. 600 mg/day Xanthigen® (300 mg PSO + 300 mg brown seaweed extract with 2.4 mg fucoxanthin). Significant weight loss, body fat reductions, and ~3 cm waist reduction. No adverse reactions over 16 weeks.

Supported by Trial 1

NAFLD liver fat content reduction

Abidov 2010 enrolled 113 women with NAFLD (liver fat >11%) plus 38 with normal liver fat (<6.5%) — the NAFLD subgroup is particularly important. Liver fat content was reduced; ALT, AST, and GGT plasma levels were reduced — clinically relevant for fatty liver disease where pharmacological options are limited. Particularly compelling intervention given the unmet need in NAFLD.

Supported by Trial 1

Resting energy expenditure increase ~400 kcal/day

Abidov 2010 documented an increase in resting energy expenditure of approximately 400 kcal/day in the active group. Distinctive thermogenic mechanism via fucoxanthin's UCP1-mediated white-to-brown adipose tissue browning — different from caffeine-based stimulant thermogenics. Provides a non-stimulant thermogenic option.

Supported by Trial 1

Blood lipid profile improvements

Abidov 2010 also reported blood lipid profile improvements. Multi-domain metabolic effects align with the proposed multi-mechanism action.

Supported by Trial 1

Inflammatory markers and blood pressure

reported inflammatory marker improvements plus blood pressure improvements. Cardiometabolic-syndrome-relevant endpoints alongside the weight and liver outcomes.

Supported by Trial 1

Synergistic patented combination (mechanism)

The combination provides multi-target weight management benefits beyond either component alone: fucoxanthin (UCP1-mediated thermogenesis) + pomegranate seed oil (punicic acid conjugated linolenic acid + antioxidant + cardiovascular effects). The synergistic positioning differentiates Xanthigen® from generic fucoxanthin or pomegranate seed oil supplements.

Supported by Trial 1, Trial 3

Pomegranate seed oil punicic acid antioxidants

Pomegranate seed oil is rich in punicic acid (a conjugated linolenic acid, 18:3 n-5) supporting cholesterol modulation, insulin sensitivity, and anti-inflammatory effects. Mechanistic complement to fucoxanthin's thermogenic action.

Supported by Trial 2, Trial 1

Mechanism of action

1

Fucoxanthin UCP1-mediated thermogenesis

Fucoxanthin (an allenic carotenoid) induces UCP1 expression in white adipose tissue, driving white-to-brown adipose tissue browning. Browned adipose tissue oxidizes fatty acids for heat rather than ATP, increasing energy expenditure — the mechanism for the observed ~400 kcal/day REE rise. Distinguishing thermogenic mechanism among weight-management supplements.

2

PPARγ and C/EBPs adipogenesis transcription factor down-regulation

Lee 2012 (J Agric Food Chem 60(4):1094-1101) — Xanthigen® suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARγ and C/EBP transcription factors. Mechanistic basis for the body fat reduction beyond simple thermogenesis.

3

SIRT-1, AMPK, and FoxO pathway modulation

Lee 2012 also documented SIRT-1, AMPK, and FoxO pathway modulation — multi-pathway metabolic regulation including longevity-associated SIRT-1 activation and AMPK-driven fatty acid oxidation.

4

Punicic acid (pomegranate) effects

Pomegranate seed oil punicic acid (conjugated linolenic acid 18:3 n-5) supports cholesterol modulation, insulin sensitivity, and anti-inflammatory effects. Distinct mechanism complementing fucoxanthin's thermogenic action.

5

Fucoxanthin antioxidant activity

Fucoxanthin is a strong singlet oxygen quencher and free radical scavenger. Antioxidant mechanism contributing to the broader metabolic benefits.

6

Hepatoprotective effects

ALT, AST, and GGT improvements in the NAFLD subgroup of Abidov 2010 reflect hepatoprotective activity — likely combining direct fatty acid oxidation effects with anti-inflammatory mechanisms.

Clinical trials

1
Abidov 2010 — Xanthigen® 16-Week NAFLD/Obesity RCT (PMID 19840063, PIVOTAL)

Abidov M et al. 2010 (PMID 19840063, Diabetes Obes Metab 12(1):72-81). 16-week double-blind randomized placebo-controlled trial in 151 non-diabetic obese premenopausal women — 113 with NAFLD (liver fat >11%) plus 38 with normal liver fat (<6.5%). 600 mg/day Xanthigen® on 1,800 kcal/day diet. Significant weight loss, body fat reductions, ~3 cm waist reduction; liver fat reduction in NAFLD subgroup; ALT/AST/GGT reductions; REE increased ~400 kcal/day; blood lipid, inflammatory marker, and blood pressure improvements. No adverse reactions. Foundational human trial supporting both weight management and NAFLD applications.

2
Lee 2012 — Xanthigen® Adipogenesis Mechanism Study

Lee J et al. 2012 (J Agric Food Chem 60(4):1094-1101). Mechanism study — Xanthigen® suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARγ and C/EBP transcription factors, plus modulation of SIRT-1, AMPK, and FoxO pathways. Comprehensive molecular characterization supporting the body fat reduction observation.

3
Maeda 2006 — Fucoxanthin Adipocyte Differentiation Suppression (Foundational)

Maeda H et al. 2006 (Int J Mol Med 18(1):147-152). Foundational fucoxanthin pharmacology — fucoxanthin and its metabolite fucoxanthinol suppress adipocyte differentiation in 3T3-L1 cells. Preclinical mechanism work that motivated the Xanthigen® clinical development.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; NO adverse reactions in 16-week Abidov 2010 trial.
GI upset (rare).
Mild iodine content from brown seaweed — caution in iodine-sensitive thyroid conditions.
Pregnancy/lactation: limited data; precautionary avoidance.
Long-term safety: 16-week trial is longest published Xanthigen data.
Allergic reactions in seaweed/seafood-allergic individuals (rare).
Pomegranate-allergy (rare).

Important Drug interactions

Anticoagulants (warfarin, DOACs): theoretical mild antiplatelet effect from pomegranate seed oil — monitor.
Antihypertensives: theoretical mild additive effects via cardiovascular mechanisms.
Thyroid medications (levothyroxine): brown seaweed iodine content — monitor TSH; may need dose adjustment.
Antidiabetic medications: theoretical compatible glucose effects; monitor blood glucose.
Statins: compatible.
Most medications: well-tolerated combination profile.

More Weight Management Ingredients

Antioxidant
Green Tea
Green tea extract, derived from Camellia sinensis leaves, is rich in antioxidants like cat…
Metabolic Health
Berberine
Berberine is a bioactive compound extracted from plants like barberry and goldenseal, know…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…
Weight Management
Capsaicin / Capsicum Extract (Cayenne Pepper)
Capsicum extract (cayenne pepper, red chili pepper) and its primary bioactive capsaicin ar…

Explore Other Ingredients

Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…
Cognitive
PQQ (Pyrroloquinoline Quinone)
Pyrroloquinoline quinone (PQQ) is a redox-active coenzyme and potent antioxidant naturally…
Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…

Frequently asked questions about Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)

What is Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)?

Branded patented blend from Nektium of wakame brown seaweed (Undaria pinnatifida) extract containing fucoxanthin plus pomegranate seed oil.

What does Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) do?

Fucoxanthin (an allenic carotenoid) induces UCP1 expression in white adipose tissue, driving white-to-brown adipose tissue browning. In clinical research, Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) has been studied for weight management and visceral fat in obese women, nafld liver fat content reduction, resting energy expenditure increase ~400 kcal/day.

Who should take Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)?

Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) may be most relevant for people interested in weight management, liver health, metabolic health. It has been clinically studied for weight management and visceral fat in obese women, nafld liver fat content reduction, resting energy expenditure increase ~400 kcal/day. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)?

Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) can typically be taken with breakfast or dinner — taking with food reduces GI sensitivity for most supplements. Specific timing matters less than daily consistency for cumulative effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) worth taking?

Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Xanthigen® (Fucoxanthin + Pomegranate Seed Oil)?

The clinically studied dose for Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) is PIVOTAL: 600 mg Xanthigen®/day × 16 weeks (300 mg PSO + 300 mg brown seaweed extract with 2.4 mg fucoxanthin). On 1,800 kcal/day diet (50% carb / 30% protein / 20% fat). Take with food. Pregnancy: avoid. Thyroid medication users: caution (iodine content from brown seaweed).. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) used for?

Xanthigen® (Fucoxanthin + Pomegranate Seed Oil) is studied for weight management and visceral fat in obese women, nafld liver fat content reduction, resting energy expenditure increase ~400 kcal/day. Abidov M et al. 2010 (, Diabetes Obes Metab 12(1):72-81) — 16-week double-blind randomized placebo-controlled trial in 151 non-diabetic obese premenopausal women on 1,800 kcal/day energy-restricted diet.